The KLOW peptide blend is a comprehensive synergistic combination of four research peptides: TB500 (10mg), BPC157 (10mg), GHK-Cu (50mg), and KPV (10mg). TB500 is studied for actin regulation and cellular migration, BPC157 for cytoprotective and tissue protection signaling, GHK-Cu for copper-dependent enzyme modulation and extracellular matrix research, and KPV for anti-inflammatory and immunomodulatory pathways. This multi-action formulation is manufactured under strict quality control standards to ensure consistency and reliability for advanced research use only.